HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MULTAQ safely and effectively. See full prescribing ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MULTAQ safely and effectively. See full prescribing ...
SR 33589 / MULTAQ (DRONEDARONE) 09 June 2009 Proposed Risk Evaluation and Mitigation Strategy (REMS) Version 7.0 Final TABLE OF CONTENTS I. GOALS ...
Page 1 of 6 © 2010 RegenceRx. All rights reserved. Therapeutic Class Review SM. Cardiovascular – Dronedarone (Multaq ®) April 2010 . Executive Summary
2/3/2011 2 Nebivolol (Bystolic®) •SUMMARY:-ß-adrenergic receptor blocking agent •BOXED WARNINGS:-None Bystolic[package insert]. St. Louis, MO: Forest ...
Initial REMS Approval: July 1, 2009 Most Recent Modification: August 5, 2011 NDA 22-425 Multaq ® (dronedarone) sanofi-aventis U.S. 55 Corporate Boulevard Bridgewater ...
Drug Office, Drug Office, Page 1 Department of Health, Department of Health, Hong Kong SAR Hong Kong SAR Drug News Drug News Drug News 藥 物 情 報 藥 物 情 報 ...
AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION MULTAQ® (DRONEDARONE) Briefing Document Advisory Committee Meeting of the Cardiovascular and Renal Drugs Division ...
www.tnpj.com 12 The Nurse Practitioner Vol. 35, No. 2 3.5 CONTACT HOURS 3.5 PHARMACOLOGY By Jennifer M. Belavic, PharmD Certolizumab pegol (Cimzia) Tumor necrosis ...
Pharmacotherapy Update 2010: New Drugs Christine M. Ruby, Pharm.D., FASCP, BCPS Assistant Professor, Departments of Pharmacy and Therapeutics and Medicine (Geriatrics ...